It’s Super Bowl Friday—Super Blue Friday, here in Seattle, where the sun shines in January. Time for a good old fashioned venture capital showdown between Seattle and New (Read more...)
Since 2008, when Scott Struthers founded San Diego’s Crinetics Pharmaceuticals, the startup has advanced its development of small-molecule drugs for treating endocrine-related disorders and cancers chiefly through (Read more...)
It looks like someone is interested in salvaging Provenge after all.
The ever-acquisitive Valeant Pharmaceuticals (NYSE: VRX) made a surprising $296 million all-cash offer late Thursday to (Read more...)
Capital Midwest Fund is courting investors as it tries to raise between $100 million and $150 million for its third fund, the Wisconsin venture capital firm told Xconomy.
Venture capital funding in the San Diego area has recovered from a three-year plunge that accompanied the U.S. financial crisis, according to a recent analysis of (Read more...)
Like most everyone else in biotech, Biogen Idec bailed out of gene therapy research over a decade ago when it looked like the tantalizing field would never deliver (Read more...)
Invenra has raised just over $2 million from investors that it will use to further develop its cell-free protein expression technology, a new SEC filing shows.
The Madison, (Read more...)
It seems Christoph Westphal had little trouble convincing public investors to back his plan to obliterate muscle cramps.
The serial biotech executive’s latest startup, Boston-based Flex Pharma, priced (Read more...)
When it comes to writing in-depth, daily stories about the business of high technology, in tech, life sciences, and beyond, we at Xconomy believe there are few news (Read more...)
It’s the moment of truth for any emerging diagnostics firm: the transition from startup to commercial-stage company. Time to convince insurers that you have something worth paying for, (Read more...)
More than 80 percent of U.S. doctors surveyed use mobile apps or view professional content on mobile devices for work. That’s a significant increase over the (Read more...)
San Francisco genomic data firm Reference Genomics says it has the tools to spot nasty microbes fast. The U.S. Centers for Disease Control and Prevention agrees.
With (Read more...)
Xenex Disinfection Services, a San Antonio, TX, robotics company that specializes in cleaning hospitals by zapping microscopic pathogens, is using a new $25 million financing round to expand (Read more...)
San Diego-based Aspyrian Therapeutics, founded in 2010 to advance technology that uses near-infrared light to activate an immune response targeting certain types of tumors, has raised (Read more...)
Duke University cardiologist Robert Califf is joining the FDA, an appointment that brings to the agency a doctor with deep experience in the development and testing of new (Read more...)